Bacteria are becoming more resistant to drugs while pharmaceutical companies are slowing their antibiotic research. Due to low profits and high time consumption, there are fewer drugs discovered and manufactured by drug companies.(1) Methicillin-resistant Staphylococcus aureus (MRSA), carbapenem-resistant Enterobacterales (CRE), and multidrug-resistant Pseudomonas aeruginosa infections...

Read More